Skip to content

The effect of High-intensity Interval Training on Cardiopulmonary Function in bedridden Stroke Patients: A Randomized Controlled Study

The effect of High-intensity Interval Training on Cardiopulmonary Function in bedridden Stroke Patients: A Randomized Controlled Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035352
Enrollment
Unknown
Registered
2020-08-09
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control group:Routine rehabilitation training

Sponsors

The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of stroke; 2. Patients with stable vital signs; 3. Patients aged >=18 years old; 4. Onset time 15 Days-1 year; 5. Patients with Mrs grade 4 or 5; 6. Patients with at least one lower limb who can actively complete hip and knee extension; 7. Patients with a score of coordination degree s5q >=3, who can understand and actively participate in the evaluation and training program; 8. Patients or family members sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects with unstable vital signs, including respiratory rate >=35 beats / min or increase >=50%; SpO2 40%); heart rate >=145 beats / min or continuous increase >=20% compared with that before the test; systolic blood pressure >=180mmhg or =38.5 degree or =200 u/L, or AST >=200u/L; 5. Patients with other serious diseases, such as malignant tumor, end stage of chronic kidney disease, mental disorder, severe malnutrition, etc; 6. Patients with nonunion of lower limb fracture and severe osteoporosis; patients with high muscle tension and Ashworth grade 2-4; 7. Patients with untreated DVT; 8. Pregnant or lactating women; 9. Patients who participated in clinical trials of other drugs or medical devices during the same period.

Design outcomes

Primary

MeasureTime frame
left ventricular ejection fraction, LVEF;NT-proBNP;stroke volume, SV;cardiac output, CO;

Secondary

MeasureTime frame
vital capacity, FVC;FEV1;FEV1/FVC;

Countries

China

Contacts

Public ContactMingling Huang

Shenzhen Second People's Hospital (the First Affiliated Hospital of Shenzhen University)

huangmeiling@szu.edu.cn+86 15999555747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 2, 2026